Allergan Promo For Acular LS Broadens Indications, FDA Warning Letter Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Journal ad for the ophthalmic misleadingly suggests the drug is indicated for phacoemulsification, according to FDA.
You may also be interested in...
‘Tis The Season… For An FDA Enforcement Letter To Alcon
The eighth enforcement letter from FDA in a decade cites the company for unjustified claims about its seasonal allergic rhinitis drug, Patanase.
After Three-Year Lull, Alcon Cited For Professional Ad Violations
DDMAC has sent five letters since 2003 for violations in promotional materials directed at health care professionals.
After Three-Year Lull, Alcon Cited For Professional Ad Violations
DDMAC has sent five letters since 2003 for violations in promotional materials directed at health care professionals.